BIIB059
230LE305
Phase 3 small_molecule active
Quick answer
BIIB059 for 1. Lupus Erythematosus, Cutaneous, Subacute 2. Chronic Cutaneous Lupus Erythematosus is a Phase 3 program (small_molecule) at Biogen Idec Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biogen Idec Ltd
- Indication
- 1. Lupus Erythematosus, Cutaneous, Subacute 2. Chronic Cutaneous Lupus Erythematosus
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active